The company plans to prioritize growth in Germany and Poland, leveraging its good manufacturing practice-certified facilities to chase higher margins. Management expects this geographic shift to improve profitability, yet the transition—compounded by April’s reductions in government-reimbursed pricing in Canada—will drive net revenue lower in fiscal 2027. Investors have responded sharply to the outlook, extending the stock's year-to-date losses to 30%.